Droxidopa NDC 70771-1610

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1610Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1610Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70771-1610-9	70771161009	90 CAPSULE in 1 BOTTLE (70771-1610-9)Marketed from Feb 19, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Droxidopa
Generic name (nonproprietary): droxidopa
Active ingredients: Droxidopa — 200 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Zydus Lifesciences Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211818
Marketing start: Feb 19, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Catecholamines (Chemical structure)Increased Blood Pressure (Physiologic effect)
Identifiers: Product ID 70771-1610_2c98c6ce-80d6-4ec5-b0a8-8305bf6ac6ebSPL ID 2c98c6ce-80d6-4ec5-b0a8-8305bf6ac6ebSPL set ID e9894e44-99ff-471a-bcc2-bfecd55a6559RxCUI 1490026, 1490034, 1490038UNII J7A92W69L7UPC 0370771160990, 0370771161096, 0370771161195

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771161009 followed by a unit qualifier and the quantity

Package 70771-1610-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 28, 2024.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211818

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211818
Product	Strength	Form · route	Labeler	Product NDC
Droxidopa	Droxidopa 100 mg/1	CapsuleOral	Zydus Lifesciences Limited	70771-1609
Droxidopa	Droxidopa 300 mg/1	CapsuleOral	Zydus Lifesciences Limited	70771-1611
Droxidopa	Droxidopa 100 mg/1	CapsuleOral	Zydus Pharmaceuticals USA Inc.	70710-1389
Droxidopa	Droxidopa 200 mg/1	CapsuleOral	Zydus Pharmaceuticals USA Inc.	70710-1390
Droxidopa	Droxidopa 300 mg/1	CapsuleOral	Zydus Pharmaceuticals USA Inc.	70710-1391